Search Within

Alexander Paul Boardman

Formats
  1. Meeting Abstract (15)
  2. Journal Article (8)
  3. Conference Paper (1)
  4. Editorial (1)
  5. Research Letter (1)
Groups
  1. Department of Medicine (26)
  2. GME, Medicine (26)
  3. Graduate Medical Education (26)
  4. Hematologic Malignancies, Division of (26)
  5. Hematology-Oncology Fellows (26)
  6. Center for Hematologic Malignancies (25)

More Groups

People
  1. Gilles Salles (19)
  2. Maria Palomba (19)
  3. Lorenzo Falchi (12)
  4. Paola Ghione (11)
  5. Santosha Vardhana (11)
  6. Alison Moskowitz (9)

More People

Years
  1. 2025 (3)
  2. 2024 (12)
  3. 2023 (9)
  4. 2022 (2)
Publications
  1. Blood (13)
  2. Blood Advances (2)
  3. International Journal of Radiation Oncology, Biology, Physics (2)
  4. Journal of Clinical Oncology (2)
  5. Blood Cancer Journal (1)
  6. Cancer Drug Discovery and Development (1)

More Publications

Publishers
  1. American Society of Hematology (15)
  2. American Society of Clinical Oncology (2)
  3. Elsevier Inc. (2)
  4. Nature Publishing Group (2)
  5. American Association for Cancer Research (1)
  6. Ferrata Storti Foundation (1)

More Publishers

Results (26)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of nivolumab plus doxorubicin, vinblastine, dacarbazine as frontline therapy in older adults with Hodgkin lymphoma
    Journal Article

    Torka, P.; Feldman, T.; Savage, K. J.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Capadona, C.; Subzwari, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Predictors and implications of renal injury after CD19 chimeric antigen receptor T-cell therapy
    Journal Article

    Boardman, A. P.; Gutgarts, V.; Flynn, J. R.; Devlin, S. M.; Goldman, A.; Tomas, A. A.; Fein, J. A.; Slingerland, J. B.; Parascondola, A.; Lin, R. J.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes
    Journal Article

    Valtis, Y. K.; Devlin, S.; Shouval, R.; Rejeski, K.; Corona, M.; De Abia, A. L.; Rivas-Delgado, A.; Luttwak, E.; Cassanello, G.; Landego, I.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Final response and survival results from a phase II trial of pembrolizumab and entinostat in relapsed/refractory Hodgkin lymphoma
    Meeting Abstract

    Stuver, R.; Vardhana, S. A.; Ganesan, N.; Boardman, A. P.; Caron, P.; Chang, T.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Impact of broad-spectrum antibiotic exposure on CAR-T therapy outcomes in B-cell lymphoma: A multicenter international study
    Meeting Abstract

    Shouval, R.; Fei, T.; Gabrielli, G.; Smith, N. G.; Ghilardi, G.; Slingerland, J.; Peled, J. U.; Taur, Y.; Nasta, S. D.; Luna, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Dual-vector-transduction with single-step magnetic selection (Zip-sort) increases transgenic payloads to enhance CAR T cell activity
    Meeting Abstract

    James, S. E.; Chen, S.; Ng, B.; Fischman, J.; Jahn, L.; Boardman, A. P.; Rajagopalan, A.; Elias, H. K.; Massa, A. R.; Manuele, D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Central nervous system bridging radiotherapy (CNS-BRT) achieves rapid cytoreduction prior to car T-cell therapy for aggressive B-cell lymphomas
    Meeting Abstract

    Cederquist, G.; Schefflein, J.; Devlin, S.; Shah, G.; Shouval, R.; Hubbeling, H.; Tringale, K.; Fregonese, B.; Hajj, C.; Boardman, A.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • A proof-of-principle study of split-course bridging radiotherapy (SC-BRT) prior to commercial CAR T-cell therapies for relapsed or refractory B-cell lymphomas: Results from phase 1a pilot cohort
    Meeting Abstract

    Imber, B. S.; Palomba, M. L.; Brosoff, A.; Roszak, E.; McAvoy, D.; Hosszu, K.; Boardman, A.; Dahi, P. B.; Lin, R. J.; Shah, G. L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Improvement in radiomic features following bridging therapy is prognostic for CD19 chimeric antigen receptor (CAR) T-cell therapy outcome
    Meeting Abstract

    Hubbeling, H. G.; Leithner, D.; Silverman, E. A.; Flynn, J.; Devlin, S.; Shah, G. L.; Fregonese, B.; Bedmutha, A.; Boardman, A.; Dahi, P. B.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Leucine zipper-based immunomagnetic purification of CAR T cells displaying multiple receptors
    Journal Article

    James, S. E.; Chen, S.; Ng, B. D.; Fischman, J. S.; Jahn, L.; Boardman, A. P.; Rajagopalan, A.; Elias, H. K.; Massa, A.; Manuele, D.; more...
    Nature Biomedical Engineering (2024)

    Fulltext@MSK | Save